United Kingdom · Series A startup

Who invested in Xampla

5 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$23Mraised across 5 rounds since 2023, from 8 sources

$5.8MSeed$1.3MSeed$622KRound$1.7MSeed$14MSeries A
Latest round
Series A, $14MSept 2025
Led by
Business Growth Fund
Step-upi
8.2×
Investors
8 (1 led)
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20242025
$5.8MSeed$1.3MSeed$622KRound$1.7MSeed$14MSeries A
First round
Seed, $5.8M
May 2023
Biggest round
$14M
Series A · Sept 2025
Usual gap between rounds
9 months
the median of 4

The rounds

  1. Sept 2025
  2. Dec 2024
    Seed$1.7M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  3. Oct 2024
    Round$622K

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  4. Nov 2023
    Seed$1.3M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

  5. May 2023
    Seed$5.8M

    No investor was named in the report.

    Shares issued, filed with Companies House (SH01); no report of this raise yet

Funding filed with regulators

Xampla filed 5 raises, $9.4M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Apr 2025Amount not statedUK share allotment
  2. Dec 2024$1.7MUK share allotment
  3. Oct 2024$622KUK share allotment
  4. Nov 2023$1.3MUK share allotment
  5. May 2023$5.8MUK share allotment

Founders and team

From Xampla's own website: 1 founder, 9 on the team.

Dr Marc Rodriguez GarciaCo-Founder & CTO
  • Alexandra FrenchCEO
  • Amelia ArmourBoard member
  • Bart SwansonBoard member
  • Dr Scott ThompsonTechnology Director
  • Ines KolmseeBoard member
  • Katrina CurlMarketing & Impact Director
  • Neil CameronBoard member
  • Pete HuttonBoard Chairman
  • Rowan BirdBoard member

AdvisersProfessor Tuomas Knowles

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Business Growth FundPrivate equity1round, led 1
Innovate UKVC firm1round
ParkwalkVC firm1round
Horizons VenturesVC firm1round
Matterwave VenturesVC firm1round
EMV CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Xampla as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Avonmore DevelopmentsFamily officePer its own site
Martlet CapitalVC firmPer its own site
regeneration.vcVC firmPer its own site

Quick answers about Xampla

Who invested in Xampla?

Xampla's investors include Business Growth Fund, Innovate UK, Parkwalk, Horizons Ventures and Amadeus Capital Partners, and 3 more on record. Business Growth Fund led its latest round.

How much has Xampla raised?

Xampla has raised $23M across 5 rounds since 2023.

When did Xampla last raise?

Xampla's most recent round was a Series A of $14M in Sept 2025, led by Business Growth Fund.

What was Xampla's biggest round?

Its most recent round, $14M in Sept 2025, is also its largest on record.

Who backed Xampla first?

Xampla's first round on record, in Sept 2025, was backed by Business Growth Fund, Innovate UK and Parkwalk and 5 others.

What stage is Xampla at?

Xampla's latest named round is a Series A, in Sept 2025.

Where is Xampla based?

Xampla is based in the United Kingdom.

Who led Xampla's rounds?

Business Growth Fund led the Series A in 2025.

Companies like Xampla

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.